Defective activity of Epstein‐Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents
- 1 October 1993
- journal article
- Published by Wiley in Pediatrics International
- Vol. 35 (5) , 394-399
- https://doi.org/10.1111/j.1442-200x.1993.tb03079.x
Abstract
Antibodies of Epstein-Barr virus (EBV), EBV-specific cytotoxic T lymphocyte (EBVCTL) activity and the lymphocyte subset of CTL were examined in 13 Japanese children with chronic active EBV infection (CAEBV) and their parents (eight fathers and 10 mothers). Anti-virus-capsid antigen (VCA)-IgG antibody titers ranged from 1:640 to 1:5120 in the patients with CAEBV and from 1:40 to 1:640 in the parents. While anti-VCA-IgM antibody was detected in three patients, anti-VCA-IgA antibody in five and anti-early-antigen (EA)-IgG antibody in 11, no antibody was detected in the parents except anti-EA antibody, which was positive in the mothers of cases 5 and 13 (1:10 and 1:40). Anti-EBV-associated nuclear antigen (EBNA) antibody was < or = 1:10 in six out of 13 patients with CAEBV and in 10 out of 18 parents tested. Epstein-Barr virus activity was significantly lower (P < 0.005) both in the children with CAEBV and in their parents than in seropositive age-matched controls. Proportions of a CTL subset (CD8+ CD11- lymphocytes) in the patients with CAEBV were significantly higher (P < 0.005) than in controls, while those in the parents were at the same level as in controls. Defective EBVCTL activity and anti-EBNA-antibody responses were frequently observed both in children with CAEBV and in their parents, which may suggest that the abnormal immune response to EBV may be based on a familial disorder, though no familial involvement has been reported in Japanese children with CAEBV.Keywords
This publication has 13 references indexed in Scilit:
- Interleukin-2 induced killer cell activity against Epstein-Barr virus-immortalized human B cellsImmunology Letters, 1989
- Chronic, symptomatic Epstein-Barr virus infectionsImmunology Today, 1986
- Cell‐mediated immunity to Epstein‐Barr virus (EBV) and natural killer (NK)‐cell activity in the X‐linked lymphoproliferative syndromeInternational Journal of Cancer, 1982
- Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP)The American Journal of Medicine, 1982
- Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.The Journal of Immunology, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative SyndromeScience, 1980
- Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytesInternational Journal of Cancer, 1978
- X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)The Lancet, 1975
- Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr VirusScience, 1970